A.C.Camargo Cancer Center at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
A.C.Camargo Cancer Center brings 3 presentations to IDWeek 2026 in Washington. Its program centres on infections in people treated for blood cancers, especially fungal disease after hematopoietic cell transplant. One study compares antifungal prophylaxis with preemptive monitoring in acute myeloid leukemia patients on venetoclax-based therapy.
| Organization | IDWeek 2026 Attendance |
|---|---|
A.C.Camargo Cancer Center São Paulo, Brazil | |
Poster Fri Oct 23 12:15pm–1:30pm Epidemiology of Invasive Fungal Disease in Allogeneic Hematopoietic Cell Transplant Recipients at a Brazilian Cancer Center (2012–2022): Preliminary Data Poster Fri Oct 23 12:15pm–1:30pm Infections During the Cytokine Release Syndrome Period After Haploidentical Hematopoietic Cell Transplantation: A 10-Year Experience from a Brazilian Cancer Center Poster Fri Oct 23 12:15pm–1:30pm Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Venetoclax-Based Therapy: Comparison of Prophylactic Versus Preemptive Monitoring Strategies |
Instantly find 20 buyers from A.C.Camargo Cancer Center
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction